To evaluate whether SFRP2 is elevated in blood from mice with metastatic osteosarcoma compared to mice without tumors, mouse serum from RF420 tumor-bearing mice was drawn at the end point (day 27), and SFRP2 protein levels were compared to the levels in non-tumor-bearing mice. The gene discussed is SFRP2; the disease is osteosarcoma.